214
Views
11
CrossRef citations to date
0
Altmetric
Research Article

An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin

, , , &
Pages 448-454 | Received 04 Oct 2017, Accepted 18 Jul 2018, Published online: 03 Oct 2018

References

  • Aggarwal BB, Sundaram C, Prasad S, Kannappan R. 2010. Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases. Biochem Pharmacol. 80:1613–1631.
  • Aioi A, Kuriyama K, Shimizu T, Yoshioka M, Uenoyama S. 1993. Effects of vitamin E and squalene on skin irritation of a transdermal absorption enhancer, lauroylsarcosine. Int J Pharm. 93:1–6.
  • Alayoubi A, Alqahtani S, Kaddoumi A, Nazzal S. 2013. Effect of PEG surface conformation on anticancer activity and blood circulation of nanoemulsions loaded with tocotrienol-rich fraction of palm oil. Aaps J. 15:1168–1179.
  • Alsarra IA, Alarifi MN. 2004. Validated liquid chromatographic determination of 5-fluorouracil in human plasma. J Chromatog B. 804:435–439.
  • Arias-Moliz MT, Ferrer-Luque CM, González-Rodríguez MP, Valderrama MJ, Baca P. 2010. Eradication of Enterococcus faecalis biofilms by cetrimide and chlorhexidine. J Endod. 36:87–90.
  • Arutchelvi J, Doble M. 2010. Characterization of glycolipid biosurfactant from Pseudomonas aeruginosa CPCL isolated from petroleum‐contaminated soil. Lett Appl Microbiol. 51:75–82.
  • Barry BW. 1987. Mode of action of penetration enhancers in human skin. J Control Release. 6:85–97.
  • Cheng Y-F, Walter TH, Lu Z, et al. 2000. Hybrid organic-inorganic particle technology: breaking through traditional barriers of HPLC separations. Lc Gc. 18:1162–1173.
  • Chouhan R, Bajpai A. 2009. An in vitro release study of 5-fluoro-uracil (5-FU) from swellable poly-(2-hydroxyethyl methacrylate)(PHEMA) nanoparticles. J Mater Sci: Mater Med. 20:1103–1114.
  • Collinsworth KA, Kalman SM, Harrison DC. 1974. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation. 50:1217–1230.
  • Edem DO. 2002. Palm oil: biochemical, physiological, nutritional, hematological, and toxicological aspects: a review. Plant Foods Hum Nutr. 57:319–341.
  • El-Say KM, Ahmed OAA, Aljaeid BM, Zidan AS. 2017. Matrix-type transdermal films to enhance simvastatin ex vivo skin permeability. Pharm Dev Technol. 22:492–499.
  • Fang J-Y, Hwang T-L, Fang C-L, Chiu H-C. 2003. In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm. 255:153–166.
  • Farrar H, Letzig L, Gill M. 2002. Validation of a liquid chromatographic method for the determination of ibuprofen in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 780:341–348.
  • FDA, Generally Recognized As Safe (GRAS) Determination for the Use of Palm Tocotrienol Rich Fractions (TRF) as Ingredients in Food. Washington, 2009. http://www.fda.gov/downloads/food/ingredientspackaginglabeling/gras/noticeinventory/ucm269421.Accessed 05 Feb 2017.
  • Ganesan M, Rauthan K, Pandey Y, et al. 2010. Determination of ibuprofen in human plasma with minimal sample pretreatment. Int J Pharm Sci Res. 1:120–127.
  • Huang Z-R, Lin Y-K, Fang J-Y. 2009. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. Molecules. 14:540–554.
  • ICH. Validation of analytical procedures: text and methodology Q2(R1). International Conference of Harmonisation of technical requirements for registration of pharmaceuticals for human use. 2005.
  • Jones M-C, Leroux J-C. 1999. Polymeric micelles - a new generation of colloidal drug carriers. Eur J Pharm Biopharm. 48:101–111.
  • Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al. 2011. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 39:D1035–D1D41.
  • Kua YL, Gan S, Morris A, Ng HK. 2016. A validated, rapid, simple and economical high-performance liquid-chromatography method to quantify palm tocopherol and tocotrienols. J Food Compost Anal. 53:22–29.
  • Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. 2003. Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release. 90:313–322.
  • Lane ME. 2013. Skin penetration enhancers. Int J Pharm. 447:12–21.
  • Malenovic A, Medenica M, Ivanovic D, Jancic B, Markovic S. 2005. Development and validation of RP–HPLC method for cetrimonium bromide and lidocaine determination. Farmaco. 60:157–161.
  • Matthäus B. 2007. Use of palm oil for frying in comparison with other high-stability oils. Eur J Lipid Sci Technol. 109:400–409.
  • Morris AP, Brain KR, Heard CM. 2009. Skin permeation and ex vivo skin metabolism of O-acyl haloperidol ester prodrugs. Int J Pharm. 367:44–50.
  • Payán MR, López MÁB, Fernández-Torres R, Bernal JLP, Mochón MC. 2009. HPLC determination of ibuprofen, diclofenac and salicylic acid using hollow fiber-based liquid phase microextraction (HF-LPME). Anal Chim Acta. 653:184–190.
  • Powell MF. 1987. Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis. Pharm Res. 4:42–45.
  • Qureshi AA, Mo H, Packer L, Peterson DM. 2000. Isolation and identification of novel tocotrienols from rice bran with hypocholesterolemic, antioxidant, and antitumor properties. J Agric Food Chem. 48:3130–3140.
  • Qureshi AA, Qureshi N, Wright JJ, Shen Z, Kramer G, Gapor A, Chong YH, DeWitt G, Ong A, Peterson DM, et al. 1991. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am J Clin Nutr. 53:1021S–1026S.
  • Rajesh S, Sujith S. 2013. Permeation of Flurbiprofen polymeric films through human cadaver skin. Int J PharmTech Res. 5:177–182.
  • Raju Y P, N H, Chowdary V H, Nair RS, Basha D J, N T. 2017. In vitro assessment of non-irritant microemulsified voriconazole hydrogel system. Artif Cells Nanomed Biotechnol. 45:1539–1547.
  • Rupilius W, Ahmad S. 2007. Palm oil and palm kernel oil as raw materials for basic oleochemicals and biodiesel. Eur J Lipid Sci Technol. 109:433–439.
  • Sambanthamurthi R, Sundram K, Tan Y-A. 2000. Chemistry and biochemistry of palm oil. Prog Lipid Res. 39:507–558.
  • Sartorelli P, Andersen HR, Angerer J, Corish J, Drexler H, Göen T, Griffin P, Hotchkiss SAM, Larese F, Montomoli L, et al. 2000. Percutaneous penetration studies for risk assessment. Environ Toxicol Pharmacol. 8:133–152.
  • Schauss AG, Endres JR, Clewell A. 2013. Safety of unsaturated vitamin e tocotrienols and their isomers. Tocotrienols: vitamin E beyond tocopherols. In: Tan B, Watson RR, Preedy VR.,editors. Boca Raton, Florida: CRC Press, Taylor and Francis.
  • Sen CK, Khanna S, Roy S. 2007. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med. 28:692–728.
  • Sen CK, Rink C, Khanna S. 2010. Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and disease. J Am Coll Nutr. 29:314S–323S.
  • Sreedharan Nair R, Nair S. 2015. Permeation studies of captopril transdermal films through human cadaver skin. Curr Drug Deliv. 12:517–523.
  • Sri P, Adimoolam S, Mahmud A. 2013. Percutaneous absorption of triacyglycerols (TAGS), tocols and carotenoids: comparison studies of crude and refined palm oil. Malay. 11:33–48.
  • Sundram K, Sambanthamurthi R, Tan Y-A. 2003. Palm fruit chemistry and nutrition. Asia Pac J Clin Nutr. 12:355–362.
  • Theriault A, Chao JT, Wang Q, Gapor A, Adeli K. 1999. Tocotrienol: a review of its therapeutic potential. Clin Biochem. 32:309–319.
  • Traber MG, Rallis M, Podda M, Weber C, Maibach HI, Packer L. 1998. Penetration and distribution of alpha-tocopherol, alpha- or gamma-tocotrienols applied individually onto murine skin. Lipids. 33:87–91.
  • Walker SE, Choudhury J, Law S, Iazzetta J. 2011. Stability of ibuprofen solutions in normal saline or 5% dextrose in water. Can J Hosp Pharm. 64:354–361.
  • Walker RB, Smith EW. 1996. The role of percutaneous penetration enhancers. Adv Drug Deliv Rev. 18:295–301.
  • Wan LS, Poon PK. 1969. Effect of salts on the surface/interfacial tension and critical micelle concentration of surfactants. J Pharm Sci. 58:1562–1567.
  • Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev. 56:603–618.
  • Wong RS, Radhakrishnan AK. 2012. Tocotrienol research: past into present. Nutr Rev. 70:483–490.
  • Zhao L, Fang L, Xu Y, Liu S, He Z, Zhao Y. 2008. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers. Eur J Pharm Biopharm. 69:199–213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.